Abbott Biotherapeutics Inactive Filings

10-Q

2009 Q1

Quarterly report

8 May 09

10-K

2008 FY

Annual report

31 Mar 09

8-K

Completion of Acquisition or Disposition of Assets

23 Apr 10

8-K

Facet Biotech Announces Two Presentations at American Academy of Neurology Annual Meeting

5 Apr 10

8-K

Entry into a Material Definitive Agreement

10 Mar 10

8-K

Results of Operations and Financial Condition

26 Feb 10

8-K

Regulation FD Disclosure

9 Feb 10

8-K

Termination of a Material Definitive Agreement

3 Feb 10

8-K

Entry into a Material Definitive Agreement

26 Jan 10

8-K

Facet Biotech Announces Enrollment of First Patient In Phase 2 Study of Elotuzumab In Patients with Relapsed Multiple Myeloma

11 Jan 10

8-K

Entry into a Material Definitive Agreement

16 Dec 09

8-K

Entry into a Material Definitive Agreement

15 Dec 09

15-12B

Securities registration termination

3 May 10

25-NSE

Exchange delisting

22 Apr 10

S-8 POS

Registration of securities for employees (post-effective amendment)

21 Apr 10

SC TO-T/A

Third party tender offer statement (amended)

20 Apr 10

SC TO-T/A

Third party tender offer statement (amended)

14 Apr 10

SC 14D9

Tender offer solicitation

13 Apr 10

SC 14D9/A

Tender offer solicitation (amended)

8 Apr 10

SC TO-T/A

Third party tender offer statement (amended)

8 Apr 10

SC 14D9/A

Tender offer solicitation (amended)

5 Apr 10

SC 14D9/A

Tender offer solicitation (amended)

30 Mar 10

DEFA14A

Additional proxy soliciting materials

1 May 09

DEF 14A

Definitive proxy

15 Apr 09

DEFA14A

Additional proxy soliciting materials

6 Apr 09

PRE 14A

Preliminary proxy

3 Apr 09

DEFA14A

Additional proxy soliciting materials

31 Mar 09

DFAN14A

Additional proxy materials by non-management

31 Mar 09

CT ORDER

Confidential treatment order

8 Nov 10

CT ORDER

Confidential treatment order

28 Apr 10

UPLOAD

Letter from SEC

1 Oct 09

UPLOAD

Letter from SEC

24 Sep 09

CT ORDER

Confidential treatment order

9 Dec 08

CT ORDER

Confidential treatment order

9 Dec 08

CORRESP

Correspondence with SEC

8 Dec 08

CORRESP

Correspondence with SEC

3 Dec 08

CORRESP

Correspondence with SEC

20 Nov 08

UPLOAD

Letter from SEC

18 Nov 08

SC 13D

ABBOTT LABORATORIES

21 Apr 10

SC 13D/A

GAMCO INVESTORS, INC. ET AL

21 Apr 10

SC 13D

GAMCO INVESTORS, INC. ET AL

16 Apr 10

SC 13D/A

BAUPOST GROUP LLC/MA

12 Apr 10

SC 13D

PERRY CORP

19 Mar 10

SC 13D/A

BAUPOST GROUP LLC/MA

17 Mar 10

SC 13D/A

CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD

10 Mar 10

SC 13D/A

BIOTECHNOLOGY VALUE FUND L P

2 Feb 10